Dg. Macgregor et al., PROTECTION BY AN ADENOSINE ANALOG AGAINST KAINATE-INDUCED EXTRAHIPPOCAMPAL NEUROPATHOLOGY, General pharmacology, 31(2), 1998, pp. 233-238
1. The glutamate analogue kainic acid produces neuronal damage in the
central nervous system. We have reported that analogues of adenosine,
such as R-N6-phenylisopropyladenosine (R-PIA) can, at doses as low as
10 mu g/kg IP, prevent the hippocampal damage that follows the systemi
c administration of kainate. The present work was designed to examine
purine protection against kainate in extrahippocampal regions by using
histological methods. 2. The results show that R-PIA, at a dose of 25
mu g/kg IP in rats, can protect against the neuronal damage caused by
kainate in the basolateral amygdaloid nuclei, the pyriform cortex and
around the rhinal fissure. This protection could be prevented by the
simultaneous administration of the Al adenosine receptor antagonist 1,
3-dipropyl-8-cyclopentylxanthine, confirming that the protection invol
ved adenosine Al receptors. No protection was observed in the posterio
r amygdaloid nuclei or the entorhinal cortex, suggesting the absence o
f relevant adenosine receptors or a different mechanism of excitotoxic
ity. (C) 1998 Elsevier Science Inc.